Pfizer CentreOne Manufacturing Network

Pfizer CentreOne is the world’s largest manufacturing cluster, with more than 200 companies and over 50,000 employees working together to develop new medicines and processes. This network of partners provides Pfizer with access to the capital markets, suppliers, raw materials and technical expertise required to manufacture its globally-recognized medicines. CentreOne offers a range of services that help manufacturers manage supply chain risk, access capital and build scale. These services include financial partnerships, warehousing and distribution centers, as well as procurement software solutions. CentreOne also hosts Pfizer’s Global Manufacturing & Logistics operations team. Leading this team are Manufacturing Operations Leaders who oversee manufacturing operations for all of Pfizer’s global pharmaceutical operations locations—including Clinical Care, Research & Early Development (R&ED), Manufacturing Production and Manufacturing Supply Chain—and partner sites in Asia Pacific and Europe.

Why Pfizer Launched CentreOne

In early 1998, Pfizer entered the healthcare IT market, acquiring the IT-enabled distribution network of SmithKline Beecham Ltd. The company’s first four acquisitions were: Pharmacia Corporation (a US-based healthcare IT company), Wyeth (a US-based pharmaceutical company), Pharmacia & Upjohn (a US-based pharmaceutical services company) and Warner Lambert (a US-based pharmaceutical ingredients company). These acquisitions provided Pfizer with a valuable portfolio of brands and proprietary technology that it integrated into its IT infrastructure to help members of its health care supply chain more effectively manage inventory and improve service delivery. In early 2004, Pfizer established its CentreOne pharmaceutical manufacturing network to further expand its global manufacturing footprint and to expand access to its portfolio of innovative medicines. CentreOne is a network of more than 200 pharmaceutical companies that use Pfizer’s technology, process development capabilities and commercial expertise to help bring new medicines to patients.

The Benefits of Being a Member of CentreOne

– Access to capital markets: Trade finance and invoice discounting services offer Pfizer’s members the opportunity to access financing from the capital markets, which helps companies manage cash surpluses, optimize working capital and reduce financial risk. – Scale: Partnering with suppliers, including contract manufacturers, helps Pfizer members source reliable and competitive raw materials for their products. This access to larger volumes of material translates into cost savings for members. – Technical expertise: CentreOne partners assist Pfizer members with their manufacturing operations, technical service, quality control, regulatory compliance and other critical functions. – Risk management: CentreOne offers services to help Pfizer members manage supply chain risks, including W&D, OOS and transportation services, which allow companies to efficiently and cost-effectively manage their operations and risks. – Partnering and collaboration: Pfizer members use CentreOne’s technology and services to strengthen and build their business relationships with suppliers. This helps members increase their overall competitiveness and access to capital markets. – Become a Pfizer Member: For more information on CentreOne and how it can benefit your organization, please visit www.pfizernetwork.org/centreon or contact your Pfizer representative.

Key Facts About Pfizer in CentreOne

– Pfizer members account for more than 70 percent of all active drugs in development. These members are committed to developing new and improved treatments for unmet medical needs. – Pfizer members generate more than 35,000 patents per year, making them major contributors to the pharmaceutical innovation ecosystem. – Pfizer members manufacture medicines to treat cancer, diabetes, pain, infection and other major diseases. – More than 8,000 Pfizer members work together in CentreOne, which is located in the United States and Europe. – CentreOne members span all stages of development, from early-stage companies to large, multi-location organizations that are well-established, but continue to grow.

Contact Raphe Pharmaceutique to learn more about Supplier Relationships with Pfizer

It is important to have good relationships with suppliers. A good supplier relationship allows you to quickly adapt to changes in demand, achieve efficiency in your production processes, and find competitive pricing from your suppliers. In addition, a good relationship with your suppliers can help you to meet regulatory requirements for quality and safety. Having good supplier relationships allows you to respond quickly to changing market conditions and make adjustments to meet customer needs quickly. Furthermore, suppliers who are important to your business are likely to be critical to your financial success. Supplier relationships are important to Pfizer members because they allow Pfizer members to respond quickly to changing market conditions and make adjustments to meet customer needs quickly. Pfizer members can also use these relationships to meet regulatory requirements for quality and safety. Pfizer also uses these relationships to help members manage supply chain risks, including W&D, OOS and transportation services, which allow Pfizer members to efficiently and cost-effectively manage operations and risks.

Conclusion

CentreOne is a network of pharmaceutical companies providing technology and expertise to help deliver innovative medicines to patients. Pfizer is a member of CentreOne and is committed to developing new and improved treatments for unmet medical needs. CentreOne offers a wide range of services, including access to capital markets, risk management and scale. CentreOne also hosts Pfizer’s Global Manufacturing & Logistics operations team. When you join CentreOne, you join a network of more than 200 companies and more than 50,000 employees working together to develop new medicines and processes to help patients around the world.